NNTWX
Price
$28.83
Change
-$0.15 (-0.52%)
Updated
Sep 18 closing price
Net Assets
918.54M
RPMGX
Price
$97.30
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
Interact to see
Advertisement

NNTWX vs RPMGX

NNTWX vs RPMGX Comparison Chart in %
View a ticker or compare two or three
VS
NNTWX vs. RPMGX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NNTWX is a Hold and RPMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 20.8B vs. NNTWX (919M). NNTWX pays higher dividends than RPMGX: NNTWX (0.02) vs RPMGX (0.00). NNTWX was incepted earlier than RPMGX: NNTWX (22 years) vs RPMGX (34 years). NNTWX (0.90) is less costly to investors than RPMGX (0.77). RPMGX is a more actively managed with annual turnover of: 31.50 vs. NNTWX (0.32). NNTWX has a lower initial minimum investment than RPMGX: NNTWX (500) vs RPMGX (2500). RPMGX annual gain was more profitable for investors over the last year : -5.63 vs. NNTWX (-10.72). NNTWX return over 5 years is better than : -19.40 vs. RPMGX (-24.20).
NNTWXRPMGXNNTWX / RPMGX
Total Expense Ratio0.900.77117%
Annual Report Gross Expense Ratio0.900.77117%
Fund Existence22 years34 years-
Gain YTD3.4820.0625,642%
Front LoadN/AN/A-
Min. Initial Investment500250020%
Min. Initial Investment IRAN/AN/A-
Net Assets919M20.8B4%
Annual Yield % from dividends0.020.00-
Returns for 1 year-10.72-5.63190%
Returns for 3 years0.33-0.19-176%
Returns for 5 years-19.40-24.2080%
Returns for 10 years18.3827.7566%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOAX11.150.01
+0.09%
Goldman Sachs Mid Cap Growth A
JOHAX29.76-0.01
-0.03%
JOHCM International Select Investor
PRHSX94.44-0.31
-0.33%
T. Rowe Price Health Sciences
THMEX16.85-0.07
-0.41%
CCT Thematic Equity Institutional
BRSYX16.90-0.09
-0.53%
MFS Blended Research Small Cap Eq R6